Adamjee Life As (ALIFE)
Pakistan Stock Exchange (PSX) · Pakistan · prices in PKR · close of 27 Oct 2026
Key indicators
| Last close | PKR 30.27 |
|---|---|
| 52-week range | 28.37 – 45.45 |
| Return, 1 month / 3 months | −0.6% / −3.6% |
| Return, 1 year / 3 years | −5.7% / +92.3% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 45.9% |
| Worst drawdown (1 year) | -30.1% |
| Average daily value traded | 0.35M PKR |
| Dividend yield | 8.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Adamjee Life Assurance Company Limited is a life insurance company based in Islamabad. It carries on life insurance business, offering cover that pays out to policyholders or their beneficiaries when an insured event occurs, and it writes non-participating business only, meaning its policies do not take part in the insurer's surplus or profits.
On this site Adamjee Life As appears as a stock on the Pakistan Stock Exchange (PSX), code ALIFE, with prices in Pakistani rupees (PKR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Adamjee Life As (ALIFE) trades on the Pakistan Stock Exchange (PSX) in Pakistan. It last closed at PKR 30.27 on 27 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 316 of 542 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.7% and over the last three months it fell 3.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Pakistan Stock Exchange (PSX)
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.8% | ||
| From 52-week high | -30.6% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.6% | ||
| 6-month return | -14.4% | ||
| 12-month return, skipping the last month | -5.2% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 45.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.1% | ||
| Liquidity | 20 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.35M PKR | ||
| Zero-volume days | 0.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 8.3% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | −0.6% |
| 3 months | −3.6% |
| 6 months | −14.4% |
| 1 year | −5.7% |
| 3 years | +92.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 30.57 / 32.49 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.29 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Sep 2026 | PKR 1.0000 |
| 20 Apr 2026 | PKR 1.5000 |
| 3 Sep 2025 | PKR 1.0000 |
| 18 Apr 2025 | PKR 1.0000 |
| 3 Sep 2024 | PKR 1.0000 |
| 16 Apr 2024 | PKR 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Pakistan Stock Exchange (PSX); it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.